ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Magilligan, D. J.
Right arrow Articles by Ausman, J. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Magilligan, D. J., Jr
Right arrow Articles by Ausman, J. I.

The Annals of Thoracic Surgery, Vol 42, 360-364, Copyright © 1986 by The Society of Thoracic Surgeons


ARTICLES

Surgical approach to lung cancer with solitary cerebral metastasis: twenty-five years' experience

DJ Magilligan Jr, C Duvernoy, G Malik, JW Lewis Jr, R Knighton and JI Ausman

From 1960 to 1985, 41 patients underwent resection of a lung cancer and one or more brain metastases. There were 24 men and 17 women ranging in age from 40 to 71 years (average, 56 years). Cell type was adenocarcinoma in 19 patients, squamous in 16, small cell in 4, and large cell in 2. Wedge resection was performed in 4 patients, lobectomy in 20, pneumonectomy in 14, and bilobectomy in 3. Brain irradiation was used for 25 patients (61%). To date, the longest survival is 18.3 years after craniotomy; mean survival is 2.3 years +/- 3.8 (+/- standard deviation). Survival was 55 +/- 7.9% (+/- standard error) at 1 year, 31 +/- 7.4% at 2 years, 21 +/- 6.5% at 5 years, and 15 +/- 6.0% at 10 years. Using multivariate analysis, we evaluated possible significant predictors of improved survival. Only wedge resection was a significant predictor (p less than .01), which suggests better results with a small peripheral lung tumor. Results of our 25 years' experience using an aggressive approach to lung cancer with solitary cerebral metastasis indicate significantly improved patient survival that justifies its widespread use.


This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. F. Kwong, M. J. Edelman, M. Suntharalingam, L. B. Cooper, Z. Gamliel, W. Burrows, P. Hausner, L. A. Doyle, and M. J. Krasna
High-dose radiotherapy in trimodality treatment of Pancoast tumors results in high pathologic complete response rates and excellent long-term survival
J. Thorac. Cardiovasc. Surg., June 1, 2005; 129(6): 1250 - 1257.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. Vesselle, E. Turcotte, L. Wiens, R. Schmidt, J. E. Takasugi, T. Lalani, E. Vallieres, and D. E. Wood
Relationship between Non-Small Cell Lung Cancer Fluorodeoxyglucose Uptake at Positron Emission Tomography and Surgical Stage with Relevance to Patient Prognosis
Clin. Cancer Res., July 15, 2004; 10(14): 4709 - 4716.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
V. Getman, E. Devyatko, D. Dunkler, F. Eckersberger, A. End, W. Klepetko, G. Marta, and M. R. Mueller
Prognosis of patients with non-small cell lung cancer with isolated brain metastases undergoing combined surgical treatment
Eur. J. Cardiothorac. Surg., June 1, 2004; 25(6): 1107 - 1113.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
A. Spira and D. S. Ettinger
Multidisciplinary Management of Lung Cancer
N. Engl. J. Med., January 22, 2004; 350(4): 379 - 392.
[Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. S. Kinch, M.-B. Moore, and D. H. Harpole Jr.
Predictive Value of the EphA2 Receptor Tyrosine Kinase in Lung Cancer Recurrence and Survival
Clin. Cancer Res., February 1, 2003; 9(2): 613 - 618.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
P. S. Billing, D. L. Miller, M. S. Allen, C. Deschamps, V. F. Trastek, and P. C. Pairolero
Surgical treatment of primary lung cancer with synchronous brain metastases
J. Thorac. Cardiovasc. Surg., September 1, 2001; 122(3): 548 - 553.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
P. Granone, S. Margaritora, A. D'Andrilli, A. Cesario, K. Kawamukai, and E. Meacci
Non-small cell lung cancer with single brain metastasis: the role of surgical treatment
Eur. J. Cardiothorac. Surg., August 1, 2001; 20(2): 361 - 366.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
P. Bonnette, P. Puyo, C. Gabriel, R. Giudicelli, J.-F. Regnard, M. Riquet, and P.-Y. Brichon
Surgical Management of Non-small Cell Lung Cancer With Synchronous Brain Metastases
Chest, May 1, 2001; 119(5): 1469 - 1475.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
K. Yokoi, N. Miyazawa, and T. Arai
Brain Metastasis in Resected Lung Cancer: Value of Intensive Follow-up With Computed Tomography
Ann. Thorac. Surg., February 1, 1996; 61(2): 546 - 550.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1986 by The Society of Thoracic Surgeons.